Drug to fight ALS gets a boost from FDA

Image: Stephen Hawking
British physicist Stephen Hawking, shown here during a 2016 interview with Larry King, is almost completely paralyzed due to ALS but still leads an active professional life (Credit: Ora.TV)

Revalesio, a biomedical company headquartered in Tacoma, Wash., says it’s been cleared to benefit from federal incentives for the development of a drug that could help treat a neurodegenerative disease known as amyotrophic lateral sclerosis, or ALS.

ALS is known as Lou Gehrig’s disease, but today’s most famous patient is British physicist Stephen Hawking, who was diagnosed with the malady more than 50 years ago.

The disease affects 12,000 to 15,000 patients in the U.S., and an estimated 6,000 Americans are diagnosed with ALS every year.

Get the full story on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributing editor at GeekWire, author of "The Case for Pluto: How a Little Planet Made a Big Difference," president of the Council for the Advancement of Science Writing. Check out "About Alan Boyle" for more fun facts.

Leave a Reply

%d bloggers like this: